(Lausanne) 13 , 1029475 (2022)
These are just some of the other uses doctors and researchers see for medications like Wegovy and Ozempic, used to treat obesity and diabetes
At clinical doses (4-12mg/week), expect $150-500/month
At 2.4 mg weekly, the average patient loses 15% to 22% of their starting body weight over 68 weeksa benchmark that guided FDA approval for Wegovy
Additionally, implementing new technologies can lead to resistance among employees who are accustomed to traditional methods
The analysis, conducted by researchers from the University of Oxford and supported by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre and the Medical Research Council, revealed that taking the drug, a popular medication for type II diabetes, had no increased risk of adverse neurological or psychiatric outcomes compared to other antidiabetic medications, challenging recent concerns about the drug's safety